Lv3
230 积分 2024-09-16 加入
Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer
6天前
已完结
Updated 5-year Survival Results from PURE-01, a Phase 2 Study of Neoadjuvant Pembrolizumab Followed by Radical Cystectomy in Patients with Muscle-invasive Bladder Cancer
6天前
已完结
Pamidronate versus zoledronic acid for the treatment of multiple myeloma–related hypercalcemia
7个月前
已完结
Revisiting the complex interactions in nocturnal polyuria: insights on OSA, ADH and ANP
7个月前
已完结
Enhancing spatial transcriptomics in clear-cell renal cell carcinoma
7个月前
已完结
SOD mineralized zeolitic imidazole framework-8 for the treatment of chemotherapy-related acute kidney injury
8个月前
已完结
皖公网安备34019202002308
